Cecilia Ley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Cecilia Ley has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
S. Ekman
2 shared publicationsA. Elmén
Addresses of authors: Department of Biomedical Sciences and Veterinary Public Health, Division of Pathology, Pharmacology and Veterinary Public Health, Swedish University of Agricultural Sciences, Box 7028, SE‐750 07 Uppsala
1 shared publication- Anders Lindahl
University of Gothenburg
1 shared publication Anna Nilton
Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
1 shared publicationB. Ronéus
1 shared publicationEmilia Svala
Division of Pathology, Pharmacology and Toxicology, Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden
1 shared publication
Latest Publications
- 30 November 2010
- Published by Taylor & Francis in Connective Tissue Research
- Vol. 52 (4) , 290-300
Effects of high mobility group box protein-1, interleukin-1β, and interleukin-6 on cartilage matrix metabolism in three-dimensional equine chondrocyte cultures
The effects of high mobility group box protein (HMGB)-1, interleukin (IL)-1β, and IL-6 on equine articular chondrocytes were investigated, with emphasis on detecting differences between anatomical sites exposed to different loading in vivo, using three-dimensional (3D) cell cultures established with chondrocytes from dorsal radial facet (DRF, highly loaded) and palmar condyle (PC, less loaded) of the third carpal bone (C3). Expression of important genes involved in cartilage metabolism, presence of glycosaminoglycans and cartilage oligomeric matrix protein (COMP) in pellets, and concentrations of matrix metalloproteinase (MMP)-13 and aggrecan epitope CS 846 were evaluated. Compared to controls, IL-1β treatment increased gene expression of versican, matrix-degrading enzymes, and tissue inhibitor of metalloproteinase (TIMP)-1, and decreased aggrecan and collagen type I and type II expression. In addition, IL-1β-treated pellets showed decreased safranin O staining and increased COMP immunostaining and MMP-13 concentrations in culture supernatants. Effects of IL-6 and HMGB-1 on gene expression were variable, although upregulation of Sry-related high-mobility group box 9 (Sox9) was often present and statistically increased in HMGB-1-treated pellets. Response to cytokines rarely differed between DRF and PC pellets. Thus, site-associated cartilage deterioration in equine carpal osteoarthritis (OA) is not explained by topographically different responses to inflammatory mediators. Differences in gene expressions of structural matrix proteins in untreated DRF and PC pellets were noted in the youngest horses, which may indicate differences in the chondrocytes potential to produce matrix in vivo. Overall, a strong catabolic response was induced by IL-1β, whereas slight anabolic effects were induced by IL-6 and HMGB-1.
- 30 November 2010
- Published by Taylor & Francis in Connective Tissue Research
- Vol. 52 (4) , 290-300
Effects of high mobility group box protein-1, interleukin-1β, and interleukin-6 on cartilage matrix metabolism in three-dimensional equine chondrocyte cultures
The effects of high mobility group box protein (HMGB)-1, interleukin (IL)-1β, and IL-6 on equine articular chondrocytes were investigated, with emphasis on detecting differences between anatomical sites exposed to different loading in vivo, using three-dimensional (3D) cell cultures established with chondrocytes from dorsal radial facet (DRF, highly loaded) and palmar condyle (PC, less loaded) of the third carpal bone (C3). Expression of important genes involved in cartilage metabolism, presence of glycosaminoglycans and cartilage oligomeric matrix protein (COMP) in pellets, and concentrations of matrix metalloproteinase (MMP)-13 and aggrecan epitope CS 846 were evaluated. Compared to controls, IL-1β treatment increased gene expression of versican, matrix-degrading enzymes, and tissue inhibitor of metalloproteinase (TIMP)-1, and decreased aggrecan and collagen type I and type II expression. In addition, IL-1β-treated pellets showed decreased safranin O staining and increased COMP immunostaining and MMP-13 concentrations in culture supernatants. Effects of IL-6 and HMGB-1 on gene expression were variable, although upregulation of Sry-related high-mobility group box 9 (Sox9) was often present and statistically increased in HMGB-1-treated pellets. Response to cytokines rarely differed between DRF and PC pellets. Thus, site-associated cartilage deterioration in equine carpal osteoarthritis (OA) is not explained by topographically different responses to inflammatory mediators. Differences in gene expressions of structural matrix proteins in untreated DRF and PC pellets were noted in the youngest horses, which may indicate differences in the chondrocytes potential to produce matrix in vivo. Overall, a strong catabolic response was induced by IL-1β, whereas slight anabolic effects were induced by IL-6 and HMGB-1.
- 1 June 2009
- Published by Elsevier in Research in Veterinary Science
- Vol. 86 (3) , 490-497
Interleukin-6 and high mobility group box protein-1 in synovial membranes and osteochondral fragments in equine osteoarthritis
- 1 June 2009
- Published by Elsevier in Research in Veterinary Science
- Vol. 86 (3) , 490-497
Interleukin-6 and high mobility group box protein-1 in synovial membranes and osteochondral fragments in equine osteoarthritis
- 20 August 2007
- Published by Wiley in Journal of Veterinary Medicine Series A
- Vol. 54 (7) , 346-351
Interleukin‐6 and Tumour Necrosis Factor in Synovial Fluid from Horses with Carpal Joint Pathology
Summary: The carpal joints are common sites of traumatic arthritis and osteoarthritis (OA) in athletic horses. The pro‐inflammatory cytokines interleukin (IL)‐6 and tumour necrosis factor (TNF) may be of great importance in the development of intra‐articular lesions. The aim of the present study was to investigate possible associations between synovial fluid levels of bioactive IL‐6 and TNF and different types of joint lesions seen in traumatic arthritis and OA. Synovial fluid was collected from horses with carpal lameness immediately before arthroscopic surgery. Articular cartilage, synovial membranes and intra‐articular ligaments were assessed macroscopically at arthroscopy. Synovial fluid levels of IL‐6 and TNF were determined by bioassays, and the cytokine levels between different grades of morphologic changes in each type of assessed tissue were compared. The highest levels of IL‐6 were detected in joints with chip fractures. All joints with chip fractures also showed some degree of synovitis. Tumour necrosis factor bioactivity was low and not associated with any joint lesion. Hence, TNF is not useful as a biomarker indicating a specific joint lesion in equine traumatic arthritis or OA. We conclude that a dramatic increase of IL‐6 in synovial fluid indicates the presence of osteochondral fragmentation, although low or undetectable levels of IL‐6 do not exclude chip fractures. The role of IL‐6 in the disease process of osteochondral fragmentation needs further investigation.
- 20 August 2007
- Published by Wiley in Journal of Veterinary Medicine Series A
- Vol. 54 (7) , 346-351
Interleukin‐6 and Tumour Necrosis Factor in Synovial Fluid from Horses with Carpal Joint Pathology
Summary: The carpal joints are common sites of traumatic arthritis and osteoarthritis (OA) in athletic horses. The pro‐inflammatory cytokines interleukin (IL)‐6 and tumour necrosis factor (TNF) may be of great importance in the development of intra‐articular lesions. The aim of the present study was to investigate possible associations between synovial fluid levels of bioactive IL‐6 and TNF and different types of joint lesions seen in traumatic arthritis and OA. Synovial fluid was collected from horses with carpal lameness immediately before arthroscopic surgery. Articular cartilage, synovial membranes and intra‐articular ligaments were assessed macroscopically at arthroscopy. Synovial fluid levels of IL‐6 and TNF were determined by bioassays, and the cytokine levels between different grades of morphologic changes in each type of assessed tissue were compared. The highest levels of IL‐6 were detected in joints with chip fractures. All joints with chip fractures also showed some degree of synovitis. Tumour necrosis factor bioactivity was low and not associated with any joint lesion. Hence, TNF is not useful as a biomarker indicating a specific joint lesion in equine traumatic arthritis or OA. We conclude that a dramatic increase of IL‐6 in synovial fluid indicates the presence of osteochondral fragmentation, although low or undetectable levels of IL‐6 do not exclude chip fractures. The role of IL‐6 in the disease process of osteochondral fragmentation needs further investigation.